When rap artist Lil Nas X revealed a diagnosis of bipolar disorder, the author Rachel Docekal observed a notable element beyond the diagnosis itself: he had long suspected something was wrong but delayed seeking care because he feared medication. That hesitation reflects a broader paradox in behavioral health: those most able to recognize illness are often most reluctant to accept treatment because they worry it will change their identity or diminish what made them successful.
High-achieving people — artists, founders, executives, athletes — commonly fear that clinical interventions will blunt the traits they associate with success. The fears take forms such as: What if medication dulls creativity? What if emotional stability reduces ambition or removes an edge? What if treating illness makes someone “ordinary”? Docekal reports hearing these concerns frequently in her work leading a behavioral health and recovery organization.
American culture simultaneously medicalizes mental illness and romanticizes its symptoms. Narratives of the troubled artist, obsessive founder, or tortured genius suggest extraordinary achievement springs from extraordinary suffering. Docekal argues these myths persist despite scientific evidence to the contrary and cautions that such stories can deter people from seeking effective care.
Docekal cites research showing that delays in diagnosis and treatment of bipolar disorder are associated with worse clinical and functional outcomes. A 2025 systematic review in The British Journal of Psychiatry found that a longer duration of untreated or undiagnosed bipolar disorder correlates with greater burden on health, relationships, and daily functioning, including higher rates of suicide attempts, comorbid anxiety disorders, alcohol use disorders, and long-term impairment. A 2023 analysis in the Journal of Patient-Reported Outcomes documented substantial human and economic burdens of bipolar disorder on occupational functioning, social relationships, health care utilization, and quality of life.
Many successful people can recall periods when symptoms and productivity coincided: building a company on little sleep, intense creative output during emotional turbulence, or relentless anxiety driving career success. Docekal stresses that what is often overlooked are the costs behind those achievements — panic attacks, insomnia, deteriorating relationships, substance dependence, and declines in overall functioning. The coexistence of symptoms and achievement can mask accumulating harm.
Docekal describes conversations with people who feared psychiatric care would diminish them. After receiving treatment, many found the opposite: improved capacity for sustained creativity, reduced chaos that had threatened ambition, and removal of barriers to expressing their personalities. She emphasizes that psychiatric medications, when properly prescribed and monitored, are tools intended to reduce symptoms that interfere with functioning and quality of life rather than to flatten emotion or erase individuality.
The author notes that treatment is not one-size-fits-all. For some individuals, medication is essential; for others, therapy, lifestyle interventions, or combinations are appropriate. The principal aim of these interventions is to help people access more of who they are beneath the symptoms, improving functioning and well-being rather than changing core identity.
Docekal highlights a gendered dimension: men remain significantly less likely than women to seek mental health treatment. Cultural norms that prize self-reliance, emotional control, and endurance contribute to this disparity. Men may view asking for help as weakness and endure suffering silently, which is reflected in higher rates of suicide, substance use disorders, and untreated mental illness. Docekal contrasts this reluctance with the readiness many show to seek medical care for physical illnesses like cardiac disease or diabetes.
The central message Docekal draws from Lil Nas X’s experience is that treatment often liberates people rather than diminishes them. She underscores that emotional suffering is not a prerequisite for exceptional achievement and that effective treatment can reduce fear, improve well-being, and enable freer creativity. In her clinical and leadership experience, people who engage in appropriate treatment frequently report greater capacity to sustain achievement and to express their personalities without the persistent interference of untreated symptoms.